Latest Natural Killer T cell Stories
- Preclinical data demonstrating iNKT cell depletion reduces inflammation and improves organ function in a murine model of sickle cell disease WALTHAM, Mass., Dec.
-- Dosing in Phase 1b Trial Complete WALTHAM, Mass., Oct. 2, 2014 /PRNewswire/ -- NKT Therapeutics today announced that the U.S.
Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe.
PharmaCo Labs today announced that PhenObestin 37.5 can help to prevent cancer, by reducing obesity and restoring the body’s healthy levels of invariant natural killer T-cells (iNKT), a special
Ongoing research by a Baylor College of Medicine pediatric oncologist to understand how special cells called natural killer T (NKT) cells can be used to suppress neuroblastoma tumor growth has led to the discovery that the protein IL-15 is key to protecting the NKT cells' anti-tumor effectiveness in a hostile environment.
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.
New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.
- A political dynamiter.